Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
This study is ongoing, but not recruiting participants.
Study NCT01269047   Information provided by Albert Einstein College of Medicine of Yeshiva University

First Received on December 29, 2010.   Last Updated on January 25, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 1 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
Hyperglycemia
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
Pramlintide
Exenatide
Insulin
Additional drug interventions recognized in this trial
Islet Amyloid Polypeptide
More general drug interventions related to this trial
Anti-Obesity Agents
Appetite Depressants
Central Nervous System Agents
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Albert Einstein College of Medicine of Yeshiva University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services